Flucelvax Pregnancy Registry: an Observational Study on the Safety of Flucelvax Exposure in Pregnant Women and Their Offspring

Trial Profile

Flucelvax Pregnancy Registry: an Observational Study on the Safety of Flucelvax Exposure in Pregnant Women and Their Offspring

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Influenza vaccine (Optaflu) (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Novartis; Seqirus
  • Most Recent Events

    • 09 Aug 2016 Status changed from recruiting to withdrawn prior to enrolment.
    • 22 Dec 2014 Planned End Date changed from 1 Dec 2020 to 1 Jun 2020 according to ClinicalTrials.gov.
    • 22 Dec 2014 Planned primary completion date changed from 1 Dec 2020 to 1 Jun 2020 according to ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top